John Hopkins University Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Glucagonlike Peptide 1-Based Therapies Associated With Acute Pancreatitis in Study
In a study by Sonal Singh, M.D., M.P.H., of The Johns Hopkins
University School of Medicine, Baltimore, and colleagues, treatment
with the glucagonlike peptide-1 (GLP-1)-based therapies sitagliptin
and exenatide were associated with increased odds... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 26, 2013 Category: Pharmaceuticals Source Type: clinical trials
Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS)
Conditions: Stem Cell Transplantation; Ventricular Dysfunction, LeftInterventions: Genetic: Lower dose mesenchymal stem cell (MSC) injection; Genetic: Placebo; Genetic: Higher dose MSC injectionSponsors: Joshua M Hare; National Heart, Lung, and Blood Institute (NHLBI); Johns Hopkins University Specialized Center for Cell Based Therapy; The EMMES CorporationCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 2, 2008 Category: Research Source Type: clinical trials